By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Kalaris Therapeutics Inc

Kalaris Therapeutics Inc (KLRS)

NASDAQ Currency in USD
$246.00
+$4.50
+1.87%
Last Update: 18 Jul 2026, 14:27
$3.76bn
Market Cap
-114.42
P/E Ratio (TTM)
Forward Dividend Yield
$172.74-$308.07
52 Week Range

KLRS Stock Price Chart

Explore Kalaris Therapeutics Inc interactive price chart. Choose custom timeframes to analyze KLRS price movements and trends.

KLRS Company Profile

Discover essential business fundamentals and corporate details for Kalaris Therapeutics Inc (KLRS) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

30 Jul 2020

Employees

14.00

CEO

Andrew Oxtoby

Description

Kalaris Therapeutics Inc. operates as a pharmaceutical enterprise. The company's core mission centers on developing innovative cell therapies. These treatments are designed to reactivate the body's inherent immunity against critical, virus-linked diseases, especially in patients with profoundly compromised immune systems.

KLRS Financial Timeline

Browse a chronological timeline of Kalaris Therapeutics Inc corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 12 Aug 2026

EPS estimate is -$0.50.

Earnings released on 12 May 2026

EPS came in at -$0.46 surpassing the estimated -$0.52 by +11.54%.

Earnings released on 17 Mar 2026

EPS came in at -$0.44 surpassing the estimated -$0.56 by +21.43%.

Earnings released on 12 Nov 2025

EPS came in at -$0.64 surpassing the estimated -$0.66 by +3.03%.

Earnings released on 13 Aug 2025

EPS came in at -$0.61 falling short of the estimated -$0.51 by -19.61%.

Earnings released on 14 May 2025

EPS came in at -$2.52 falling short of the estimated -$0.78 by -223.08%.

Earnings released on 7 Mar 2025

EPS came in at -$3.64 falling short of the estimated -$2.76 by -31.84%.

Stock split effective on 16 Jan 2025

Shares were split 1 : 23 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 12 Nov 2024

EPS came in at -$0.04 surpassing the estimated -$0.14 by +71.43%.

Earnings released on 30 Jun 2024

EPS came in at -$1.13 surpassing the estimated -$2.37 by +52.18%.

Earnings released on 31 Mar 2024

EPS came in at -$0.68 surpassing the estimated -$3.62 by +81.09%.

Earnings released on 31 Dec 2023

EPS came in at -$0.70 surpassing the estimated -$9.84 by +92.88%.

Earnings released on 30 Sept 2023

EPS came in at -$8.94 .

Earnings released on 30 Jun 2023

EPS came in at -$11.00 .

Earnings released on 31 Mar 2023

EPS came in at -$10.15 .

Earnings released on 31 Dec 2022

EPS came in at -$9.42 .

Earnings released on 30 Sept 2022

EPS came in at -$11.39 .

Earnings released on 30 Jun 2022

EPS came in at -$15.93 .

Earnings released on 31 Mar 2022

EPS came in at -$15.76 .

Earnings released on 31 Dec 2021

EPS came in at -$20.96 .

Earnings released on 30 Sept 2021

EPS came in at -$16.62 .

KLRS Stock Performance

Access detailed KLRS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run